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Abstract
 
The development of naive CD4
 
 
 
 T cells into a T helper (Th) 2 subset capable of producing in-
terleukin (IL)-4, IL-5, and IL-13 involves a signal transducer and activator of transcription
(Stat)6-dependent induction of GATA-3 expression, followed by Stat6-independent GATA-3
autoactivation. The friend of GATA (FOG)-1 protein regulates GATA transcription factor ac-
tivity in several stages of hematopoietic development including erythrocyte and megakaryocyte
differentiation, but whether FOG-1 regulates GATA-3 in T cells is uncertain. We show that
FOG-1 can repress GATA-3–dependent activation of the IL-5 promoter in T cells. Also, FOG-1
overexpression during primary activation of naive T cells inhibited Th2 development in CD4
 
 
 
T cells. FOG-1 fully repressed GATA-3–dependent Th2 development and GATA-3 autoacti-
vation, but not Stat6-dependent induction of GATA-3. FOG-1 overexpression repressed de-
velopment of Th2 cells from naive T cells, but did not reverse the phenotype of fully commit-
ted Th2 cells. Thus, FOG-1 may be one factor capable of regulating the Th2 development.
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Introduction
 
In development, lineage commitment decisions can be ini-
tiated by transient gradients of factors that regulate gene ex-
pression. The early effects of transient signaling can become
stabilized by feedback pathways such as transcriptional au-
toactivation (1), in which a transcription factor induces its
own expression. For example, autoactivation of Pit-1 and
GATA-2 occurs in the developing pituitary after their tran-
sient induction by FGF-8 and BMP2/4 (1), stabilizing cel-
lular commitment to expression of specific pituitary hor-
mones. Transcriptional autoactivation also occurs for the
transcription factor GATA-1 in hematopoietic develop-
ment (2), MyoD in muscle development (3, 4), and reti-
noic acid X receptor (5), suggesting it may be a common
developmental strategy for lineage commitment. We re-
cently showed that GATA-3 also exerts transcriptional au-
toactivation in development of the Th type 2 (Th2) subset
of CD4
 
 
 
 T cells (6). In this system, transient signaling by
IL-4 receptors during activation of naive T cells causes sig-
nal transducer and activator of transcription (Stat)
 
*
 
6-depen-
dent elevation in GATA-3 expression followed by a switch
to Stat6-independent GATA-3 autoactivation (6, 7).
Transcriptional autoactivation reinforces developmental
choices, but creates a problem of regulating a potentially
runaway feedback pathway. For Th2 development, this
problem arises because naive T cells express a basal level of
GATA-3 that potentially could autoactivate in the absence
of IL-4 signaling. However, despite basal GATA-3 expres-
sion in naive T cells, Stat6-independent autoactivation is
found to occur inefficiently, in 
 
 
 
5–10% of T cells (6).
Therefore, a threshold may exist that must be overcome
before autoactivation can efficiently occur.
The physical basis for this threshold is unknown. Con-
ceivably, there may be a requirement for IL-4–induced
Stat6 activation in establishing GATA-3–dependent tran-
scription of the GATA-3 gene. This does not appear to be
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the case, however, since autoactivation of endogenous
GATA-3 expression can be established by ectopic GATA-3
even in the absence of IL-4 and in Stat6-deficient T cells
(6). A threshold for GATA-3 autoactivation could also be
established by factors that partially repress GATA-3 activ-
ity. Friend of GATA (FOG)-1 was identified as a GATA-1
interacting factor and shown to enhance GATA-1–depen-
dent transcriptional activity (8). FOG-1 contains multiple
zinc finger domains, four of which are capable of interact-
ing with the NH
 
2
 
-terminal zinc finger of the GATA fam-
ily of transcription factors. In particular, zinc fingers 1, 5,
6, and 9 of FOG-1 interact with the N zinc finger domain
of GATA-1. Initially, FOG-1 was found to be capable
of activating GATA-1–dependent responses. Subsequent
studies have also found that both FOG-1 and FOG-2 can
exert repressive activities of GATA-dependent responses
(9–11). FOG-1 can interact with GATA-3 in yeast two-
hybrid analysis (8), but its effects in T cells have not been
examined.
In this study, we examined the effect of FOG-1 in regu-
lating the transcriptional activity of GATA-3 in developing
CD4
 
 
 
 T cells. We find that FOG-1 exerts an inhibitory
rather than an activating role in regulating GATA-3–
dependent transcription in CD4
 
 
 
 T cells. Further, our re-
sults indicate that FOG-1 can exert this activity primarily at
relatively low levels of GATA-3 expression and selectively
in naive T cells, but not in fully differentiated Th2 cells where
GATA-3 levels are much higher. FOG-1 appears to selec-
tively regulate GATA-3 autoactivation, and specifically re-
presses the Stat6-independent, GATA-dependent induction
of GATA-3 expression, but does not repress IL-4 driven,
Stat6-dependent GATA-3 expression.
 
Materials and Methods
 
Reagents.
 
Wild-type and Stat6-deficient DO11.10 
 
 
 
/
 
  
 
TCR transgenic mice have been described previously (12, 13).
Cytokines and antibodies were obtained as described previ-
ously (6).
 
T Cell Activation and Phenotype Differentiation.
 
DO11.10 sple-
nocytes were purified by density gradient (Histopaque-1119;
Sigma-Aldrich) and activated by 0.3 
 
 
 
M chicken OVA peptide
323–339 at 3 
 
 
 
 10
 
6
 
 cells per milliliter in IDME media. For Th1
development, T cells were activated in the presence of IL-12 (10
U/ml) and anti–IL-4 antibody 11B11 (10 
 
 
 
g/ml) (14). For Th2
development, cells were activated in the presence of anti–IL-12
(TOSH) (3 
 
 
 
g/ml; reference 15) and IL-4 (100 U/ml). For pas-
sage, T cells were harvested 7 d after the previous activation,
washed, and restimulated with 0.3 
 
 
 
M OVA at 1.25 
 
 
 
 10
 
5
 
 cells
per milliliter and irradiated Balb/c splenocytes (2,000 rads, 2.5 
 
 
 
10
 
6 
 
cells per milliliter).
 
Constructs and Retroviral Infection.
 
The green fluorescent pro-
tein (GFP)-RV vector has been described previously (16). We
modified GFP-RV to create GFPR1-RV, allowing EcoR1 clon-
ing of cDNAs into the multiple cloning sites (MCS) as follows.
GFP-RV was used as template in a PCR with the following oli-
gonucleotide primers: MCS1: 5
 
 
 
 GGG AGA TCT AAA CTC
GAG AAA GAA TTC TAA CGT TAC TGG CCG AAG; and
GFP-AS: 5
 
 
 
 GAA TTC GGA TCC TTA CTT GTA CAG
CTC GTC C. The PCR product contains the internal ribosomal
 
entry site/GFP cassette from GFP-RV, which now lacks the
original 3
 
 
 
 EcoR1 site and making the MCS EcoR1 site unique.
This product was digested with BglII and BamHI and ligated
with the 5.1-Kb backbone of BglII/BamHI-digested GFP-RV to
produce GFPR1-RV. A 3.3-Kb EcoR1 fragment containing
full-length FOG-1 cDNA was digested from pMT2-FOG-1 (8)
and ligated into the EcoR1 site of GFPR1-RV. Integrity of the
full-length FOG-1 cDNA was confirmed by sequencing. A full
length murine GATA-3 cDNA was generated using R/m
GATA-3 (J.D. Engel, Northwestern University, Evanston, IL;
reference 17) as template in a PCR reaction with the following
oligonucleotides as primers: GATA-3–5
 
 
 
: GAATTCGTCGAC-
GCTCTGCCTCTCTAACCCAT; and GATA-3–3
 
 
 
: GAATT-
CGTCGACGGACATGGAGGTGACTGCGGA.
This product was digested with SalI and ligated into XhoI-
digested hCD4-RV (18) to generate GATA-3-hCD4-RV. Ret-
rovirus was produced and transfections performed as described
previously (13). For coinfection experiments, viral supernatants of
FOG-1-RV and GATA-3-hCD4-RV were added together on
day 2 Th1 cells and infected T cells were sorted on day 7 for dual
expression of GFP and hCD4 using monoclonal anti–human
CD4 directly conjugated with R-PE (Caltag).
 
Northern and Western Blot Analysis.
 
Total RNA was isolated
by Rneasy kit (QIAGEN). RNA (5 
 
 
 
g per lane) was electro-
phoresed and transferred to Zeta probe membrane (Bio-Rad Lab-
oratories). A FOG-1 cDNA probe was generated using the fol-
lowing oligonucleotide primers: FOG1-S: 5
 
 
 
 CTG TCG GCC
TTC ACC ACC AA; and FOG-1-AS: 5
 
 
 
 GTG CCT TGT CAG
CGG GAA CC. The HPRT, GAPDH, and GATA-3 probes
have been described previously (13, 19). Blots were probed with
murine monoclonal anti–GATA-3 antibody HG3–31 (Santa Cruz
Biotechnology, Inc.), a murine polyclonal anti–FOG-1 serum (8),
and polyclonal anti–murine ZAP-70 serum (20).
 
IL-5 Reporter Analysis.
 
To generate a high copy number IL-5
reporter construct, we obtained the wild-type IL-5 reporter orig-
inally generated in the vector pXP1 (21) and moved it into the
vector pBS-LUC (22) as follows. The pXP1 IL-5 reporter con-
struct was digested with HindIII and BamHI, and the liberated
1.7 Kb IL-5 promoter fragment ligated into HindIII/BamHI-
digested pBS-LUC, generating IL-5-LUC. We used the Renilla
luciferase vectors pRL-TK or pRL-CMV (Promega) to normal-
ize Firefly luciferase transfections.
To express GATA-3 in transient transfections, the GATA-3
PCR product generated above using R/m GATA-3 and primers
GATA-3–5
 
 
 
 and GATA-3–3
 
 
 
 was digested with SalI and ligated
to into XhoI-digested vector pcDNA3.1 (Invitrogen) to generate
the plasmid GATA-3-pcDNA (8). 10 
 
 
 
 10
 
6
 
 EL-4 cells on ice
were electroporated in 1 ml at 960 
 
 
 
F and 320V (22) with com-
binations of GATA-3-pcDNA and PMT2-FOG-1 as described
in the Figure legends. After 12 h, cells were either left untreated
or activated by 25 ng/ml PMA and 1 mM Bt2cAMP for 6 h as
indicated in the Figure legends and luciferase activity measured as
described previously (22).
 
Analysis of FOG-1–deficient T Cells by RAG2 Blastocyst Comple-
mentation.
 
The CJ-7 ES cell line was previously used to generate
FOG-1
 
 
 
/
 
 
 
 single targeted and FOG-1
 
 
 
/
 
 
 
 
 
doubly targeted ES
clones FOG3.31 and FOG3.3.11.10 (23). 10 ES cells were injected
into recombination activating gene (RAG)-2–deficient blastocysts
as described previously (24). Two chimeras each were analyzed for
FOG-1
 
 
 
/
 
 
 
 single targeted and FOG-1
 
 
 
/
 
 
 
 doubly targeted ES
clones. Analysis of thymocyte subsets (see Fig. 7 A) was performed
as described previously (25). To analyze IL-4 production, intracel-
lular staining was performed as described previously (6). 
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Results
 
FOG-1 Is Expressed in both Th1 and Th2 by CD4
 
 
 
 T
Cells.
 
We first considered FOG-1, FOG-2, BCl-6, and
CIITA expression in T cells during the induction of Th1
and Th2 subsets (Fig. 1 A). The mRNAs for BCl-6, FOG-2,
and CIITA were essentially undetectable in T cells un-
der either Th1 or Th2 conditions after 2 or 4 d of activa-
tion (data not shown). Although CIITA expression in Th1
cells has been reported by one group, it was detected only
by RT-PCR, and not by Northern or RNase protection
(26). In contrast, FOG-1 mRNA was detectable by
Northern blot analysis (Fig. 1 A). Expression was relatively
low in naive T cells, induced somewhat by stimulation
with anti-CD3 and anti-CD28 antibodies. The induction
of both Th1 and Th2 development requires T cell activa-
tion, so that the increase in FOG-1 expression seen upon
activation may indicate a potential regulatory role for
FOG-1 in phenotype development. Expression was essen-
 
tially the same between Th1- and Th2-inducing condi-
tions and was maintained at relatively similar levels from
naive T cells to day 7, not showing significant elevation in
expression after Th differentiation (Fig. 1 A). By contrast,
GATA-3 expression was barely detectable by Northern
blot analysis in naive T cells, but became strongly and se-
lectively expressed during Th2 development. Thus, in
early T cells, mRNA for FOG-1 is in relative excess to
GATA-3, whereas in differentiated Th2 cells GATA-3 is
in relative excess to FOG-1.
We confirmed this result by Western blot analysis,
checking whether FOG-1 became differentially expressed
in differentiated Th1 or Th2 cells at the level of protein ex-
pression (Fig. 1 B). FOG-1 was expressed at essentially the
same level in either resting or restimulated cells and in Th1
and Th2 cells (Fig. 1 B, top). As a control, we found that
GATA-3 protein is highly expressed in resting and acti-
vated Th2 cells, but essentially undetectable in Th1 cells.
 
FOG-1 Represses GATA-3–dependent Transcriptional Ac-
tivity.
 
FOG-1 activates GATA-1 transcription at the NF-
E2 promoter (8), but represses GATA-1 activity at the
M1
 
 
 
 and the EKLF promoters (27) in transfection assays
and during erythropoiesis in injected 
 
Xenopus
 
 embryos
(10). These results suggest that the activity of FOG-1 may
differ in distinct promoter contexts. While FOG-1 can in-
teract with GATA-3 in a yeast two-hybrid system (8), no
functional studies of FOG-1 interactions with GATA-3
have been reported.
To test if FOG-1 activates or represses GATA-3–depen-
dent activity in T cells, we used the GATA-3–dependent
reporter system based on the IL-5 promoter (28). First, we
established the linear range for GATA-3 in which increas-
ing GATA-3 expression caused an increase in PMA/
Bt2cAMP-induced reporter activity (Fig. 2 A), consistent
with the dose–dependent effects of GATA-3 on the IL-5
promoter (28). Using a linear range of GATA-3 cotransfec-
tion, we next asked if FOG-1 could activate or repress
GATA-3–dependent IL-5 promoter activity (Fig. 2 B).
FOG-1 expression alone had no effect on activating IL-5
reporter activity (Fig. 2 B). As expected, GATA-3 expres-
sion increased PMA/Bt2cAMP-inducible reporter activity
(Fig. 2 B). Coexpression of FOG-1 with GATA-3 almost
completely inhibited GATA-3–induced reporter activity
(Fig. 2 B). Inhibition by FOG-1 of GATA-3–dependent
reporter activity was dose–dependent (Fig. 2 C), was maxi-
mal at 15 
 
 
 
g of FOG-1 plasmid, and saturated at 
 
 
 
80% in-
hibition. In summary, FOG-1 represses GATA-3–depen-
dent IL-5 promoter activity.
 
FOG-1 Overexpression in Naive T Cells Represses Th2
Development.
 
We wished to determine if FOG-1 also inhib-
ited  GATA-3–dependent transcriptional activity in non-
transformed T cells. For this we used retroviral gene trans-
fer to express FOG-1 in antigen-activated DO11.10 T cells
(Fig. 3 A). First, we asked if expressing FOG-1 early during
development would alter acquisition of a Th2-cytokine
pattern induced by IL-4 (Fig. 3 B). In T cells activated in
Figure 1. FOG-1 is not selec-
tively expressed in Th1 or Th2
cells. (A) T cells from DO11.10
TCR-transgenic mice were
stimulated with 0.3  M OVA
peptide in the presence ( ) of
either IL-4 (100 U/ml) or IL-12
(10 U/ml) as indicated or with
that anti-cytokine antibodies ( )
specific for IL-4 (11B11, 10  g/
ml; reference 14) or IL-12
(TOSH 3  g/ml) (reference 15).
Cells were harvested on the indi-
cated day after activation and to-
tal RNA prepared. Northern
blot analysis for the indicated
transcripts was performed as de-
scribed previously (reference 13).
For lanes 1 and 2, naive T cells were purified by cell sorting as described in
the Materials and Methods and left untreated or activated with anti-CD3
and anti-CD28 for 20 h and RNA prepared for Northern blot analysis for
FOG-1 and GATA-3 expression. (B) T cells activated in the indicated pri-
mary as described in A were harvested on day 7, and activated for 12 h
with plate-bound anti-CD3 (5  g/ml) and either left untreated (media)
or activated with anti-CD3 (5  g/ml), and Western blot analysis sequen-
tially performed for FOG-1, GATA-3, and ZAP-70. 
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Figure 2. FOG-1 inhibits
GATA-3–dependent IL-5 pro-
moter activation. (A) 107 EL-4
cells were electroporated with
IL-5-Luc (20  g), pRL-TK (5
 g) and the indicated micro-
grams of GATA-3-pcDNA
(GATA-3) and pcDNA3.1 (In-
vitrogen). After 16 h, cells were
left untreated (open bars) or
treated with PMA/Bt2cAMP
(closed bars) for 6 h and lu-
ciferase activity determined.
Values shown are the relative
Firefly luciferase activity after normalization by Renilla luciferase activity
of pRL-TK. The results were repeated twice. (B) 107 EL-4 cells were
transfected with the IL-5-Luc and pRL-TK as above, with additions ( )
of GATA-3-pcDNA (6  g) and pMT2-FOG-1 (20  g) as indicated. 6
 g of pcDNA3.1 and 20  g pMT2 were added in replacement ( ) to
equalize total DNA between samples. After 16 h, cells were left un-
treated (white bars) or treated with PMA/Bt2cAMP (black bars) for 6 h
and luciferase activity determined and analyzed as in A. The experiment
was repeated five times with similar results. (C) EL-4 cells were trans-
fected with IL-5-Luc (20  g), pRL-CMV (5  g), and the indicated mi-
crograms of GATA-3-pcDNA and pMT2-FOG-1. To equalize DNA
between samples, equal amounts of pcDNA3.1, or pMT2 were added in
replacement as in B above. Cells were stimulated and analyzed as in A.
The data are presented as fold-induction over the unstimulated IL-5 re-
porter activity in the condition without GATA-3 and FOG addition
(lane 1). The experiment was repeated four times with similar results.
Figure 3. FOG-1 overexpression in naive T cells represses Th2 devel-
opment. (A) Retroviral constructs. (B) T cells from unimmunized
DO11.10 TCR transgenic mice were activated using 0.3  M OVA pep-
tide and conditions inducing either Th1 (10 U/ml IL-12 and 10  g/ml anti–IL-4) or Th2 (100 U/ml IL-4 and 3  g/ml anti–IL-12) development and
infected by GFP-RV or FOG-1-RV virus after 36 h. CD4  GFP  T cells were purified by cell sorting on day 7 and restimulated with OVA, and ex-
panded for 7 d. T cells were restimulated (1.25   105 cells per milliliter) with 0.3  M OVA peptide, and cytokines measured by ELISA as described pre-
viously. Similar results were obtained in six independent experiments. (C) Cells in B were expanded for 1 wk and activated with PMA (50 ng/ml) and
ionomycin (1  M) overnight. Whole cell lysates (5   106 cells per lane) were analyzed by Western blot analysis for expression of FOG-1 and ZAP-70. 
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the presence of IL-4, retroviral overexpression of FOG-1
partially inhibited IL-5 and IL-4 expression compared with
T cells infected with the empty control retrovirus. FOG-1
inhibited IL-4 production by 
 
 
 
70%, and inhibited IL-5 by
 
 
 
50% (Fig. 3 B). In five additional independent experi-
ments, overexpression of FOG-1 consistently inhibited IL-4
expression by between 50 to 80%. While inhibition of IL-4
production was not complete, the effects of FOG-1 were
selective for Th2 cells, since IFN-
 
 
 
 production was not af-
fected (data not shown, and Fig. 5).
As a control, we verified by Western blot analysis that
the retroviral expression of FOG-1 significantly increased
FOG-1 protein content in these cells (Fig. 3 C). This ex-
periment also verified that the level of endogenous FOG-1
is similar between Th1 and Th2 cells as found above (Fig. 3
C, compare lanes 1 and 2). Thus, overexpression of FOG-1
repressed IL-4-induced Th2 development, consistent with
it acting as a repressor of GATA (ROG)-3–dependent ac-
tivity in the transient transfection system.
We next asked if FOG-1 could repress Th2 cytokines in
fully differentiated cells. T cells that had undergone 1 wk of
previous differentiation were infected with FOG-1–
expressing and control retroviruses (Fig. 4). At this time
point, overexpression of FOG-1 did not significantly re-
press Th2 cytokine production (Fig. 4 A), even though
FOG-1 protein levels were significantly elevated as before
(Fig. 4 B). This result suggests that FOG-1 can act as a re-
pressor primarily during an early step in Th2 development.
 
FOG-1 Inhibits GATA-3–induced Th2 Development.
 
FOG-1 could repress Th2 development either by inhibit-
ing Stat6-dependent processes or a GATA-3–dependent
process. To distinguish these possibilities, we performed a
series of coinfection experiments in which FOG-1 and
GATA-3 were independently expressed by different retro-
viral vectors. Since retroviral GATA-3 expression can in-
duce Th2 development independently of Stat6 and in
Stat6-deficient cells (6, 13), coexpressing FOG-1 with
GATA-3 allows a direct test of its role in the GATA-3–
dependent Th2 development.
First, we performed coinfection studies in wild-type T
cells that contain Stat6, activated in Th1-inducing condi-
tions, where Stat6 activation may be prevented using a
neutralizing anti–IL-4 antibody. T cells activated in Th1-
inducing conditions were infected with combinations of
FOG-1 and GATA-3 retroviruses on day 2 and infected
cells purified by two-color cell sorting on day 7. Under
Th1 conditions, the GATA-3 retrovirus induced IL-4 and
IL-5 production and inhibited IFN-
 
 
 
 production (Fig. 5 A)
consistent with previous findings (6, 13, 29). In contrast,
the FOG-1 retrovirus did not induce Th2 development or
inhibit IFN-
 
 
 
 production (Fig. 5 A). However, when
FOG-1 and GATA-3 both expressed in a dual infection,
the FOG-1 significantly inhibited the extent of GATA-3–
induced Th2 development (Fig. 5 A).
In the above experiment, IL-4 induced by the retroviral
GATA-3 may not be completely neutralized by antibody,
Figure 4. FOG-1 overexpression in differentiated Th2 cells does not repress cytokine
production. T cells from unimmunized DO11.10 TCR transgenic mice were activated us-
ing 0.3  M OVA peptide and conditions inducing either Th1 (10 U/ml IL-12 and 10  g/
ml anti–IL-4) or Th2 (100 U/ml IL-4 and 3  g/ml anti–IL-12) development and allowed
to develop for 7 d. T cells were then restimulated with OVA/APCs and infected with
GFP-RV or FOG-1-RV virus after 36 h. CD4  GFP  T cells were purified by cell sorting
after another 6 d. Cells were then immediately activated (1.25   105 cells per milliliter with
0.3  M OVA and irradiated APCs) and cytokine production measured by ELISA. (B) Cells
in A were expanded for 1 wk and activated with PMA (50 ng/ml) and ionomycin (1  M)
overnight. Whole cell lysates (5   106 cells per lane) were analyzed by Western blot analysis
for expression of FOG-1 and ZAP-70. Similar results were obtained in three additional in-
dependent experiments.1466 FOG-1 Represses GATA-3 Activity
allowing for potential Stat6-dependent induction of
GATA-3 in T cells. To eliminate this possibility, we re-
peated these coinfection experiments using Stat6-deficient
DO11.10 T cells also activated under Th1-inducing condi-
tions (Fig. 5 B). In this setting, retroviral GATA-3 expres-
sion strongly induced Th2 development, with high IL-4
and IL-5 production (Fig. 5 B). However, when FOG-1
and GATA-3 were now coexpressed, FOG-1 almost com-
pletely inhibited GATA-3–induced Th2 development (Fig.
5 B), with IL-4 production nearly undetectable, and with
 10-fold reduced IL-5. Additionally, FOG-1 coexpression
with GATA-3 increased IFN-  production fourfold in
Stat6-deficient T cells. These results suggest that FOG-1
can repress GATA-3–induced Th2 development.
FOG-1 Inhibits GATA-3 Autoactivation, but not Stat6–
dependent GATA-3 Induction. Since retroviral GATA-3
can induce expression of the endogenous GATA-3 gene (6),
we wanted to ask whether FOG-1 could repress GATA-3
autoactivation. Northern blot analysis can distinguish be-
tween the retrovirally derived and the endogenous cellular
transcripts for both GATA-3 and FOG-1. On Northern
blots, endogenous GATA-3 transcripts migrate at  3.8 Kb
and retroviral GATA-3 transcripts migrate at 4.6 Kb. En-
dogenous FOG-1 migrates at 3.4 Kb and retroviral FOG-1
at 6.5 Kb.
We first examined wild-type T cells that express Stat6, in
which FOG-1 only incompletely blocked GATA-3–induced
Th2 development (Fig. 6 A). T cells were activated in
Th1-inducing conditions, infected on day 2 with FOG-1
or GATA-3 retroviruses, purified by two-color cell sorting
on day 7, expanded, and analyzed by Northern and West-
ern blot analysis (Fig. 6 A). Retroviral GATA-3 infection
induced the expression of endogenous GATA-3 transcripts
(Fig. 6 A, lane 3), consistent with previous findings (6).
Retroviral FOG-1 did not induce endogenous GATA-3
transcription (Fig. 6 A, lane 2). Coinfection of FOG-1 with
GATA-3 reduced the relative level of induction of endog-
enous GATA-3 both as measured by Northern blot analysis
(Fig. 6 A, lane 4) and also as measured by Western blot
analysis (Fig. 6 B, compare lane 3 and 4).
To directly test whether FOG-1 can repress IL-4–depen-
dent and Stat6-dependent induction of GATA-3, we also
examined GATA-3 protein expression of FOG-1–infected
cells activated in the presence of IL-4 (Fig. 6 B, lane 6). Im-
portantly, in these Th2-inducing conditions, retroviral
FOG-1 expression did not reduce GATA-3 levels. Thus, in
T cells expressing Stat6, FOG-1 partially represses GATA-3
autoactivation induced by retroviral GATA-3, but this re-
pression may be incomplete since some IL-4 produced by
some T cells (Fig. 3 B) could potentially induce endogenous
GATA-3 through the Stat6-dependent pathway. However,
in this condition, the transcriptional effect of GATA-3 that
is expressed can still be inhibited by FOG-1, since we ob-
served 50–80% decrease in IL-4 production (Fig. 3 B).
Figure 5. FOG-1 represses
GATA-3–induced Th2 in Stat6-
deficient T cells. T cells from
unimmunized DO11.10 TCR
transgenic mice were activated
using 0.3  M OVA peptide and
conditions inducing either Th1
(10 U/ml IL-12 and 10  g/ml
anti–IL-4) or Th2 (100 U/ml
IL-4 and 3  g/ml anti–IL-12)
development as indicated. After
36 h, cells were infected ( )
with GFP-RV, FOG-1-RV, or
GATA-3-RV as indicated. Ret-
rovirally infected T cells were
purified for the appropriate
markers on day 7 by cell sorting,
and expanded once with OVA
and APCs for an additional 7 d.
T cells were purified a second
time by cell sorting, immediately
stimulated with OVA/APC as
described in Fig. 3, and cytokine
production measured by ELISA.
Similar results were obtained in
six independent experiments.
(B). Stat6-deficient (Stat6 / ) or
wild-type (WT) DO11.10 T
cells from unimmunized mice
were activated using 0.3  M
OVA peptide and conditions in-
ducing either Th1 (10 U/ml IL-
12 and 10  g/ml anti–IL-4) or
Th2 (100 U/ml IL-4 and 3  g/ml anti–IL-12) development as indicated. After 36 h, T cells were infected ( ) with GFP-RV, FOG-1-RV, or
GATA-3-RV as indicated. Cells were purified for the appropriate retroviral markers on day 7 by cell sorting and expanded once. Then (on day 14), T
cells were purified a second time by cell sorting and activated as above, and cytokines measured by ELISA.1467 Zhou et al.
To completely eliminate Stat6-dependent induction of
GATA-3 and examine FOG-1 repression of GATA-3 au-
toactivation in isolation, we repeated the experiment now
using Stat6-deficient T cells (Fig. 6 C). As expected, T cells
activated in Th1 conditions and infected by empty retrovi-
rus showed no expression of endogenous GATA-3 (Fig. 6
C, lane 1). Retroviral GATA-3 again strongly induced the
expression of endogenous GATA-3 transcripts (Fig. 6 C,
lane 2). However, now in Stat6-deficient T cells, the coex-
pression of FOG-1 with GATA-3 caused a very significant
reduction in the level of endogenous GATA-3 transcrip-
tion induced by retroviral GATA-3 (Fig. 6 C, compare
lanes 2 and 3). This result suggests that FOG-1 can repress
the transcriptional activity of the GATA-3 protein in driv-
ing the expression of the endogenous GATA-3 locus.
Analysis of FOG-1–deficient T Cells Using RAG-2 Blasto-
cyst Complementation. Embryonic lethality prevents direct
analysis of mature FOG-1–deficient T cells (23). There-
fore, we attempted to generate normal mature T cells by
producing chimeras using complementation of RAG-2 / 
blastocysts with ES cells targeted at both FOG-1 alleles (23)
(Fig. 7). In such chimeras, mature T and B cells are exclu-
sively derived from FOG-1–targeted ES cells. For controls,
we generated chimeras with an ES cell targeted on only
one FOG-1 allele (23).
Overall thymocyte numbers in FOG-1 /  chimeras
were greatly reduced relative to FOG-1 /  chimeras
(Fig. 7 A). FOG-1 /  chimeras were nearly devoid of
CD4 CD8  (DP) thymocytes (2%) (Fig. 7 A, top) com-
pared with control FOG-1 /  chimeras which showed the
normal majority of DP thymocytes (82%). In FOG-1 / 
chimeras, CD4 CD8  (DN) thymocytes were the major-
ity, similar to unreconstituted RAG-2 /  mice. Analysis of
DN thymocytes showed a block in the transition from
CD44 /CD25  to CD44 /CD25   in FOG-1 / 
thymocytes, indistinguishable to RAG-2 /  thymocytes,
whereas this transition occurred normally in FOG-1 / 
thymocytes (Fig. 7 A, bottom). Endogenous RAG-2 / 
DN thymocytes are present in all these chimeras, and with-
out additional analysis we cannot precisely conclude at
which step before the DP stage the FOG-1 /  thymocytes
development arrests. Some single positive CD4  or CD8 
thymocytes T cells are present in FOG-1 /  thymuses de-
spite the lack of DP thymocytes, distinguishing them from
totally unreconstituted RAG-2 /  thymuses, although it is
unclear how these thymocytes developed in the absence of
a DP population. Finally, mature B cells were identified at
similar numbers in the spleens of FOG-1 /  chimeras and
FOG-1 /  chimeras (data not shown). These results could
either indicate a requirement for FOG-1 in DP thymocyte
development, or reflect poor T cell reconstitution by this
particular FOG-1 /  ES clone.
Despite poor thymocyte development in FOG-1 / 
chimeras, we attempted to identify potential effects on
Th1/Th2 development by purifying the peripheral CD4 
T cells from FOG-1 /  and FOG-1 /  chimeras. Periph-
eral CD4  T cell numbers in FOG-1 /  chimeras were
significantly lower than in FOG-1-/  chimeras, preventing
Figure 6. FOG-1 represses Stat6-independent GATA-3 autoactiva-
tion. (A and B) Cells analyzed for cytokine expression in Fig. 5 A were
expanded for 7 d, activated with PMA and ionomycin for 12 h, and total
RNA prepared. Northern blot analysis (A) for expression of the retrovi-
ral and endogenous FOG-1 and GATA-3 transcripts, and GAPDH was
performed. Western blot analysis (B) was performed for GATA-3 and
ZAP-70. (C) Cells analyzed for cytokine expression in Fig. 5 B were ex-
panded for 7 d, activated with PMA and ionomycin for 12 h, and total
RNA prepared. Northern blot analysis for retroviral and endogenous
GATA-3 expression, and GAPDH expression was performed.1468 FOG-1 Represses GATA-3 Activity
isolation of cells sufficient for direct biochemical (Northern
and Western) blot analysis, but sufficient for in vitro activa-
tion (Fig. 7 B). Activation of these T cells by antibodies,
rather than by antigen, was necessary since these thy-
mocytes are not on a TCR-transgenic background, but on
the 129/Sv genetic background of CJ-7 ES cell (23). Thus,
we included activation of Balb/c T cells as a control for this
difference in genetic background and activation method.
Naive FOG-1 / , FOG-1 / , or Balb/c T cells were
purified by cell sorting and activated with plate bound anti-
CD3/CD28 antibodies under various initial conditions
(Fig. 7 B). In Th1 conditions, each population failed to ac-
quire IL-4 production (Fig. 7 B, Th1). Similarly low levels
of IL-4 production were seen when all cytokines (e.g.,
IL-4, IL-12, and IFN- ) were neutralized (Fig. 7 B, Neu).
In Th2 conditions, Balb/c T cells acquired a strong Th2
phenotype, with 49% cells positive for IL-4 production.
However, both the FOG-1 /  and FOG-1 /  T cells be-
came only weakly positive for IL-4 production, with 6.5 and
11% of cells producing IL-4 under these same Th2 condi-
tions (Fig. 7 B). FOG-1 /  T cells were less positive for
IFN-  intracellular staining under Th1 conditions (24%)
compared with FOG-1 /  T cells (40%; data not shown).
These results could indicate a general problem with cytokine
production in FOG-1–deficient T cells, related either to ab-
normal reconstitution or to the absence of FOG-1.
Figure 7. FOG-1–deficient thymocytes exhibit devel-
opmental arrest and inefficient production of mature
CD4  T cells. (A) Thymuses were harvested from 4-wk-
old FOG-1 /  or FOG-1 /  RAG-2 chimeras or age-
matched RAG-2 /  mice and analyzed by FACS®. Total
thymocyte numbers are shown above the FACS® profiles.
Thymocytes were stained for CD4, CD8, CD44, and
CD25 expression as described previously (reference 25).
Numbers shown are the percentage of live gated cells in
each quadrant. (B) Peripheral CD4  CD62L  (L-selectin)
T cells from the spleens and lymph node of FOG-1 /  or
FOG-1 /  chimeras or unimmunized Balb/c mice were
purified by cell sorting using FITC-conjugated rat anti–
mouse CD4 and phycoerythrin-conjugated rat anti-CD62L.
T cells were activated using plate bound anti-CD3 (5  g/
ml) and anti-CD28 (1  g/ml) essentially as described pre-
viously (reference 43). The indicated conditions cytokines
conditions were imposed: Th1, IL-12 (3  g/ml), and
anti–IL-4 (11B11, 10  g/ml); Th2, IL-4 (100 U/ml),
anti–IL-12 (TOSH, 3  g/ml; reference 15); Neutralized
(Neu), anti–IL-12, anti–IL-4, and anti–IFN-  (H22 10
 g/ml); or without any cytokine or antibody addition
(Drift). Cells were allowed to proliferate and expand for 7 d
and were harvested, restimulated, and analyzed for IL-4
production by intracellular staining as described previously
(6). Numbers in the upper right are the percentage of live
gated cells in this quadrant. Similar results were obtained in
two experiments1469 Zhou et al.
More importantly, differences in genetic background
prevent strong conclusions from these RAG-2 chimera
studies. Even under Th2-inducing conditions, 129/sv-
derived T cells showed much less efficient IL-4 production
than Balb/c T cells, independently of FOG-1 deficiency.
This effect could be due to differences in genetic back-
ground (30–35). Further, in unmanipulated conditions
(Fig. 7 B, Drift), Balb/c T cells became 39% positive,
whereas FOG-1 /  or FOG-1    T cells became essen-
tially negative, at 2% and  1% positive for IL-4 produc-
tion, demonstrating the sensitivity of default Th2 develop-
ment to variations in genetic background. While, we
intended to test if FOG-1 deficiency caused constitutive
GATA-3 autoactivation, we can only conclude that
FOG-1–deficient T cells do not acquire a default Th2 phe-
notype under these in vitro conditions, and were unable to
directly analyze GATA-3 expression. Thus, we must tem-
per our conclusions due to possible artifacts induced by
poor thymocyte development in these chimeras and to dif-
ferences in genetic background between 129/sv and Balb/c
T cells for default Th2 development.
Discussion
Th2 development can be divided into two phases (7); an
initial phase in which a transient excess of IL-4 induces
GATA-3 expression in a Stat6-dependent manner (13) fol-
lowed by a phase in which GATA-3 promotes its own
transcription (i.e., autoactivation) in a Stat-6–independent
manner, stabilizing GATA-3 expression and Th2 develop-
ment (6). Since naive activated T cells express detectable
levels of GATA-3 even without IL-4 treatment (6), we
wondered whether T cells contain factors capable of con-
trolling GATA-3–dependent transcription and thereby
generating a threshold for GATA autoactivation. In this
study we considered factors known to interact with GATA
family members. FOG-1 and FOG-2 could potentially re-
press GATA-3–dependent transcription. However FOG-2
was not detectable in T cells. FOG-1 is detectable in both
naive and differentiated CD4  T cells. FOG-1 was ex-
pressed slightly higher in activated naive T cells than resting
naive T cells, but was similar between Th1 and Th2 condi-
tions. Thus, we wondered whether FOG-1 could act to in-
hibit GATA-3–dependent transcriptional activity in T
cells. Our findings suggest that FOG-1 can repress GATA-
3–dependent promoter activity, and repress the GATA-3–
dependent induction of Th2 development, but does not
block Stat6-dependent processes, such as IL-4–induced
transcription of GATA-3.
We have not examined all possible factors that could
regulate GATA-3 autoactivation. The zinc finger protein
ROG has been reported to exert an inhibitory effect in T
cells that may be related to its ability to interact with
GATA proteins (36). ROG was identified initially as a
GATA-3–interacting protein, and when overexpressed in
T cell clones exerted repression of both Th1 and Th2 cyto-
kines, with effects shown for IFN- , IL-4, and IL-5 (36).
ROG-1 is induced within 24 h of activation under both
Th1 and Th2 conditions, so conceivably could also partici-
pate in regulating GATA-3–dependent autoactivation (36).
However, so far the effects of introducing ROG by over-
expression have been examined in fully differentiated T cell
clones, and not in early developing primary T cells. Thus,
the effect that ROG could potentially have on GATA-3
expression has not been examined.
Other factors could also help regulate GATA-3–depen-
dent transcriptional activity, including but not limited to
CIITA (26), BCl-6 (37), and T-bet (38), since each of
these factors opposes Th2 cytokine expression in one way
or another. At present, these factors are not thought to di-
rectly regulate GATA-3 transactivation, but rather to exert
independent effects on downstream targets. For example,
GATA-3 levels were reported to be independent of CIITA
expression (26). However, it will be interesting to deter-
mine their potential for directly regulating GATA-3 auto-
activation as well.
FOG-1 contains repetitive zinc finger motifs, with zinc
fingers 1, 5, 6, and 9 capable of interacting with GATA-1
N finger (39). FOG-1 may inhibit GATA-dependent tran-
scriptional activity in part by recruiting CtBP2, a local tran-
scriptional repressor (40). A short protein motif, PIDLS, lo-
cated between zinc fingers 6 and 7 of FOG-1 mediates
interaction with CtBP2 (40). Not all repression may in-
volve CtBP2, however, since the NH2 terminus of FOG-2
exerts transcriptional inhibition independently of its ability
to bind CtBP2 (41).
We propose that FOG-1 may be one factor that can reg-
ulate GATA-3–dependent transcriptional activity in T
cells. This effect could occur either by recruiting CtBP2
(or other corepressors) into the GATA-3 transcriptional
complex, or by direct repression of GATA-3 transcrip-
tional activity. In either model, the level of inhibition
caused by FOG-1 depends on relative amounts of FOG-1
and GATA-3. When GATA-3 is low, as in naive T cells,
fixed levels of FOG-1 might bind a larger fraction of
GATA-3, and more effectively repress GATA-3–depen-
dent transcription. Our data showed that FOG-1 only re-
pressed GATA-3–induced processes, including GATA-3
autoactivation and Stat6-independent Th2 development,
but not the IL-4–induced, Stat6-driven GATA-3 expres-
sion. In this way, FOG-1 might regulate GATA-3 activity
in naive T cells, but not block the Stat6-dependent IL-4–
driven induction of GATA-3. Importantly, FOG-1 expres-
sion is not strongly induced in Th2 development, so that
higher levels of GATA-3 in Th2 cells results in a smaller
FOG-1–bound fraction, and less repression. This is consis-
tent with our finding that overexpression of FOG-1 in dif-
ferentiated Th2 cells did not inhibit IL-4 or IL-5 produc-
tion (Fig. 4 A). Since germline deletion of FOG-1 (23) and
GATA-3 (42, 43) are both lethal, testing these models for
T cells in vivo is difficult. We attempted to analyze
FOG-1–deficient T cells for altered Th2 development us-
ing RAG-2 blastocyst complementation, but we are unable
to draw firm conclusions from these experiments. More1470 FOG-1 Represses GATA-3 Activity
definitive tests of FOG-1’s role in regulating Th2 develop-
ment will likely require a inducible deletion of FOG-1.
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